NURO NeuroMetrix, Inc. Net Sales Margin

Public company logo of NeuroMetrix Corp (NURO)

The profit margin of NeuroMetrix, Inc. (NURO) is under pressure due to falling demand for legacy systems and a shortage of funds. The business relies on Quell devices to combat neuropathy using unique neurostimulation, although retail price wars are limiting profitability. The value of -257.40 determines this parameter level, filtering out random fluctuations to identify the actual effectiveness of cost management.

neurometrix.com (NURO) Net Return on Sales: for the period 07/04/2022 - 05/11/2025

Summary analytical data breakdowns for NeuroMetrix Corporation (NURO)

- market value and analyst target forecast:
Summary company analysis:NeuroMetrix Corporation - NURO
Manufactured product of NeuroMetrix Corp

NeuroMetrix, Inc. (NURO) specializes in high-tech devices for neurostimulation and the rapid diagnosis of diabetic neuropathy. By analyzing the net profit margin, an investor assesses the portion of profit remaining after covering all operating expenses. This metric measures the efficiency of monetizing medical developments and the business's resilience to market shocks. The stability of this indicator confirms the strength of the asset's market value. This chart's price action allows for the determination of the investment cycle phase and the risks of a future correction in returns.

Analysis of competing companies